Table 1 |
|
| Distribution of disease categories | |
| Groups | Findings and number of dogs |
| SRMA untreated (SRMA) | Dogs with fever, cervical pain, neutrophilic leukocytosis and pleocytosis. These dogs were not pre-treated with glucocorticosteroid (n = 36) |
| SRMA relapse (SRMA R) | Dogs with a previous diagnosis of SRMA in which clinical signs recurred despite glucocorticosteroid treatment (n = 9) |
| SRMA therapy (SRMA Th) | Dogs with previous diagnosis of SRMA under long-term glucocorticosteroid treatment. These dogs did not show any clinical signs at the time of sampling (n = 20) |
| Idiopathic epilepsy (IE) | Dogs with clinical, CSF, MRI findings consistent with idiopathic epilepsy (n = 22) |
| Meningoencephalomyelitides (ME) | Dogs with clinical, CSF, MRI and/or pathological findings consistent with meningoencephalomyelitides: granulomatous meningoencephalomyelitis (n = 14), necrotising encephalitides (n = 1), meningoencephalomyelitis of unknown origin (n = 8), infectious encephalitides (n = 24) |
| Miscellaneous non-inflammatory CNS diseases (CNS-Mix). | Dogs with miscellaneous not primarily inflammatory neurological diseases: intervertebral disc disease (n = 9), neoplasia of the CNS (n = 24), cerebrovascular disease (n = 4), degenerative myelopathy (n = 1) |
| Systemic inflammatory diseases (Syst. Inflam.) | Dogs affected with systemic inflammatory diseases, but not suffering from neurological conditions (n = 16) |
| Healthy | Healthy dogs (n = 20) |
CSF: cerebrospinal fluid; CNS: central nervous system; MRI: magnetic resonance imaging; SRMA: steroid-responsive meningitis-arteritis.
Maiolini et al. BMC Veterinary Research 2013 9:23 doi:10.1186/1746-6148-9-23
